Bradley Merrill Thompson Quoted in Article, “‘Voice of Mobile Health’ Predicts FDA’s Final Guidance Will Not Mean More Rules”

MedCity News

Bradley Merrill Thompson, a Member of the Firm in the Health Care and Life Sciences practice, in the Washington, DC, office, was quoted in an article titled "'Voice of Mobile Health' Predicts FDA's Final Guidance Will Not Mean More Rules."

Following is an excerpt:

While the FDA demurs on issuing its final guidance over which medical and consumer health apps come under its jurisdiction, mobile health developers are operating in a state of confusion. ?...

"The MRC believes the timely release of the final guidance will benefit industry, stimulate investment, help ensure patient safety and is consistent with the views expressed by Congress," MRC representative Bradley Merrill Thompson stated in a letter. Merrill Thompson is an attorney with the Washington-based law office of Epstein Becker & Green. ?...

"Some people mistakenly believe that the final guidance will expand FDA jurisdiction. It will not," Merrill Thompson writes in the two-page document addressed to Secretary Sebelius.